Recalls / Class III
Class IIID-0478-2024
Product
Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC 71384-640-01
- Affected lot / code info
- Lot #: 23JUL028, Exp. Date 8/1/2024; 23AUG053, Exp. Date 8/30/2024
Why it was recalled
Out of specification for assay
Recalling firm
- Firm
- Imprimis NJOF, LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 1705 Route 46 Ste 6B, Ledgewood, New Jersey 07852-9720
Distribution
- Quantity
- 15,414 units
- Distribution pattern
- Nationwide within the United States
Timeline
- Recall initiated
- 2024-04-10
- FDA classified
- 2024-04-30
- Posted by FDA
- 2024-05-08
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0478-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.